Finanzdaten der Citius Pharmaceuticals Inc-Aktie (CTXR)
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 10.41%1.49 | 1.67 | 3.94 | - | - |
| Cost Of Revenue | 49.55%0.49 | 0.33 | 0.79 | - | - |
| Gross Profit | 25.14%1.00 | 1.34 | 3.15 | - | - |
62.03%12.73 | 33.53 | 12.17 | 8.44 | 8.79 | |
| Research and Development | 35.48%1.05 | 1.63 | 1.60 | 1.64 | 1.62 |
| Interest Income/Expense | 0.20 | - | - | - | - |
| Operating Income/Loss | 63.56%-11.73 | -32.19 | -9.02 | -8.44 | -8.79 |
107.64%-0.29 | 3.85 | -0.11 | -0.04 | -0.15 | |
| Interest And Debt Expense | 1.11%0.03 | 0.03 | 0.05 | - | - |
| Income/Loss From Continuing Operations Before Tax | 57.56%-12.03 | -28.34 | -9.13 | -8.48 | -8.94 |
| Income Tax Expense/Benefit, Deferred | 53.57%-0.11 | -0.23 | 0.26 | 0.26 | 0.26 |
| Income Tax Expense/Benefit | 53.57%-0.11 | -0.23 | 0.26 | 0.26 | 0.26 |
57.60%-11.92 | -28.11 | -9.39 | -8.74 | -9.20 | |
| Available To Common Stockholders, Basic | 58.26%-8.86 | -21.23 | -8.22 | -7.96 | -8.79 |
| Attributable To Noncontrolling Interest | 55.57%-3.06 | -6.88 | -1.17 | -0.78 | -0.41 |
| Basic Average Shares | 16.95%26.17 | 22.38 | 21.50 | 2.04 | 11.01 |
| Diluted Average Shares | 16.95%26.17 | 22.38 | 21.50 | 2.04 | 11.01 |
| Basic Earnings Per Share | 64.21%-0.34 | -0.95 | -0.38 | -0.11 | -0.80 |
| Diluted Earnings Per Share | 64.21%-0.34 | -0.95 | -0.38 | -0.11 | -0.80 |